# Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing

> **NCT06036563** · — · RECRUITING · sponsor: **Air Force Military Medical University, China** · enrollment: 3200 (estimated)

## Conditions studied

- Cancer Diagnosis
- LungCancer
- Gastric Cancer
- Liver Cancer
- Colorectal Cancer
- Esophagus Cancer
- Breast Cancer
- Pancreas Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06036563
- **Lead sponsor:** Air Force Military Medical University, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2025-08
- **Final completion:** 2025-12
- **Target enrollment:** 3200 (ESTIMATED)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06036563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06036563, "Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06036563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*